PNW vs SGMO · P/E 19, rev $2.61B vs rev $57.8M
Pinnacle West Capital Corp (PNW) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
PNW currently screens at market cap $12.41B and trailing P/E 19.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the PNW and SGMO stock pages for the full models.
Not investment advice.